Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for autoimmune and inflammatory diseases, degenerative diseases, and cancer-related to the liver. Its clinical pipeline includes drug assets for Crohn's Disease, COVID19, Secondary Progressive Multiple Sclerosis, and Hepatocellular Carcinoma. Its development pipeline includes Foralumab, Milciclib, Anti-IL6R, and Others. The company has a single reporting segment, which is the research and development of biotechnological & pharmaceutical products.
Quote | Tiziana Life Sciences plc (NASDAQ:TLSA)
Last: | $0.90 |
---|---|
Change Percent: | -3.53% |
Open: | $0.88 |
Close: | $0.90 |
High: | $0.97 |
Low: | $0.859 |
Volume: | 262,505 |
Last Trade Date Time: | 07/22/2024 03:00:00 am |
News | Tiziana Life Sciences plc (NASDAQ:TLSA)
2024-06-28 16:10:13 ET More on Tiziana Life Sciences Tiziana spikes as FDA clears additional patients for expanded access program Financial information for Tiziana Life Sciences Read the full article on Seeking Alpha For further details see: Tiziana annou...
NEW YORK, June 28, 2024 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough therapies in neurodegenerative disease secondary to active neuroinflammatory processes today announced t...
Message Board Posts | Tiziana Life Sciences plc (NASDAQ:TLSA)
Subject | By | Source | When |
---|---|---|---|
https://newsdirect.com/news/tiziana-life-sciences-reports-six-month-pet-scan-res | Count Crypto | investorshub | 10/18/2023 3:31:48 PM |
Tiziana Life Sciences Announces Allowance By FDA For | Ryguy008 | investorshub | 10/18/2023 1:07:13 PM |
News https://marketwirenews.com/news-releases/tiziana-life-sciences-announces- | Count Crypto | investorshub | 10/18/2023 11:16:15 AM |
The now | Anita Dump | investorshub | 10/17/2023 11:06:07 PM |
https://marketwirenews.com/articles/tiziana-life-sciences-plc-nasdaq-tlsa-short- | Count Crypto | investorshub | 10/17/2023 9:16:52 PM |
News, Short Squeeze, Breakout and More Instantly...
Tiziana Life Sciences plc Company Name:
TLSA Stock Symbol:
NASDAQ Market:
Tiziana Life Sciences plc Website:
NEW YORK, June 28, 2024 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough therapies in neurodegenerative disease secondary to active neuroinflammatory processes today announced t...
--News Direct-- Tiziana Life Sciences Ltd (NASDAQ:TLSA) chairman and CEO Gabriele Cerrone joined Proactive's Stephen Gunnion with more details of the company's recent advancements and news. Tiziana Life Sciences is developing a fully human CD3 monoclonal antibody, delivered intranasally, ...
NEW YORK, June 26, 2024 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies via novel routes of drug delivery, today announced that the U.S. Food and Dru...